The purpose of this study is to find out whether a urine test can detect colorectal cancer (CRC) and precancerous polyps in participants living in Ghana, Tanzania, and South Africa.
Study Type
OBSERVATIONAL
Enrollment
210
3-metabolite biosensor will identify participants with colorectal cancer (CRC) and precancerous polyps
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
New York, New York, United States
RECRUITINGKorle Bu Teaching Hospital (Data Collection Only)
Accra, Ghana
NOT_YET_RECRUITINGWits Donald Gordon Medical Centre (Data Collection Only)
Johannesburg, South Africa
Sensitivity of 3-metabolite biosensor
The study will validate a 3-metabolite biosensor that identifies participants with colorectal cancer (CRC) and precancerous polyps in Ghana, Tanzania and South Africa. The primary aim is to show that the sensitivity and specificity in other regions are as good as the Nigerian estimates (i.e. 90% and 80% respectively).
Time frame: up to 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Kilimanjaro Christian Medical Centre (Data Collection Only)
Moshi, Tanzania
NOT_YET_RECRUITING